Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma

Abstract

BACKGROUND Although sorafenib is considered standard therapy for advanced hepatocellular carcinoma (HCC), actual treatments vary. We evaluated the effects of different treatment strategies on overall survival. METHODS A retrospective study of sorafenib-treated patients with advanced HCC was conducted. The primary outcome was overall survival. Prognostic… (More)
DOI: 10.18632/oncotarget.11030

Topics

8 Figures and Tables